TNF and hepatocellular carcinoma: Specifically, the authors showed that blocking trained immunity by metformin, which can inhibit the trained immunity property of BCG by reducing the production of IL-6 and Tumor necrosis factor-α (TNF-α), abrogates the anti-HCC effect of BCG (33).